Specialty Pharmaceuticals Industry Financials, Performance and Ratios
-
Industry Score
22.9 /100
Rank 113 out of 131 Industries -
Advance/Decline
14/14
-
No. of Companies28
-
Avg. Market Cap2,268
-
Price to Earning Ratio-
-
Price to Earning Growth Ratio0.23
-
Price to Book Ratio26.21
-
Return on Equity32.34
-
Return on Capital Employed-
-
Return on Assets23.71
-
Dividend yield 1 year %0.00
-
Net Profit Growth Annual YoY %-152.59 %
-
Net Profit Growth Qtr YoY %-223.57 %
-
Net Profit Growth Qtr QoQ %67.72 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Specialty Pharmaceuticals Industry Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Specialty Pharmaceuticals Peer comparison
Compare all stocks in Specialty Pharmaceuticals industry listed on stock exchanges
| Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch Health Companies Inc |
|
2,434.7
|
6.5
|
L
 -3.3%
H
6.5
6.8
|
L
 -6.1%
H
6.4
7.1
|
L
 47.0%
H
4.5
7.3
|
L
 19.0%
H
4.3
7.3
|
L
 -10.8%
H
4.3
8
|
L
 -21.0%
H
4.0
11.5
|
L
 -77.4%
H
4.0
29.6
|
L
 -79.1%
H
4.0
34.8
|
| Bellring Brands Inc |
|
1,254.6
|
10.8
|
L
 0.3%
H
10.6
11.0
|
L
 4.0%
H
10.2
11.0
|
L
 -16.7%
H
10.1
14.2
|
L
 21.1%
H
7.8
14.3
|
L
 -72.1%
H
7.8
43.0
|
L
 -73.4%
H
7.8
80.7
|
L
 -67.2%
H
7.8
80.7
|
L
H
7.8
80.7
|
| Usana Health Sciences Inc |
|
252.6
|
13.7
|
L
 -0.8%
H
13.5
13.9
|
L
 3.5%
H
12.9
14.0
|
L
 -35.9%
H
12.6
23.6
|
L
 -27.1%
H
12.6
23.6
|
L
 -57%
H
12.6
32.3
|
L
 -78.6%
H
12.6
65.2
|
L
 -85.7%
H
12.6
104.0
|
L
 -80.1%
H
12.6
138.0
|
| Biondvax Pharma Ltd (ADR) |
|
-
|
2.9
|
L
 -8.0%
H
2.7
3.2
|
L
 1100%
H
0.2
3.6
|
L
 1152.2%
H
0.2
3.6
|
L
 526.1%
H
0.2
3.6
|
L
 87.0%
H
0.2
3.6
|
L
 118.2%
H
0.2
6.2
|
L
 -87.8%
H
0.2
99
|
L
 -92.3%
H
0.2
620
|
| Niagen Bioscience Inc |
|
261.1
|
3.3
|
L
 0.9%
H
3.2
3.3
|
L
 7.8%
H
3.1
3.3
|
L
 2.8%
H
2.9
3.6
|
L
 -9.8%
H
2.9
4.0
|
L
 -67.1%
H
2.9
10.5
|
L
 120%
H
1.3
14.7
|
L
 -59.3%
H
1.2
14.7
|
L
 -12.5%
H
1.2
23.7
|
| Cronos Grp Inc |
|
1,307.9
|
3.6
|
L
 1.1%
H
3.5
3.6
|
L
 10.6%
H
3.2
3.6
|
L
 26.3%
H
2.7
3.6
|
L
 29.6%
H
2.6
3.6
|
L
 39.2%
H
2.3
3.6
|
L
 110.1%
H
1.6
3.6
|
L
 -45.5%
H
1.6
6.8
|
L
 914.3%
H
0.3
25.1
|
| Enveric Biosciences Inc |
|
6.1
|
1.4
|
L
 -6.2%
H
1.2
1.5
|
L
 1.5%
H
1.2
1.5
|
L
 6.2%
H
1.2
1.8
|
L
 -38.0%
H
1.2
2.4
|
L
 -91.4%
H
1.2
17.6
|
L
 -99.6%
H
1.2
525.6
|
L
 -100.0%
H
1.2
33660
|
L
 -100.0%
H
1.2
12150000
|
| ZeroStack Corp |
|
100.6
|
5.8
|
L
 -11.1%
H
5.3
6.2
|
L
 212.5%
H
1.5
12.4
|
L
 296.6%
H
1.3
12.4
|
L
 34.4%
H
1.3
12.4
|
L
 -74.1%
H
1.3
47
|
L
 -93.2%
H
1.3
213.7
|
L
 -99.9%
H
1.3
8385
|
L
H
1.3
16731
|
| Jupiter Wellness Inc |
|
45.0
|
1.2
|
L
 2.5%
H
1.1
1.2
|
L
 30.1%
H
1.0
1.2
|
L
 8.0%
H
0.9
1.2
|
L
 -35.3%
H
0.9
2.1
|
L
 168.9%
H
0.1
7.2
|
L
 9.0%
H
0.1
7.5
|
L
 -30.1%
H
0.1
7.5
|
L
H
0.1
8.9
|
| Lifevantage Corp |
|
83.4
|
6.6
|
L
 -3.4%
H
6.5
6.8
|
L
 3.8%
H
6.4
6.9
|
L
 1.2%
H
6.2
7.0
|
L
 17.8%
H
5.5
11.7
|
L
 -48.9%
H
3.9
14.3
|
L
 33.3%
H
3.9
27.4
|
L
 -12.7%
H
3.0
27.4
|
L
 -54.7%
H
2.9
27.4
|
| Mannatech Inc |
|
13.7
|
7.1
|
L
 10.1%
H
6.2
7.1
|
L
 9.2%
H
6.0
7.1
|
L
 57.8%
H
4.5
7.1
|
L
 62.5%
H
4.0
7.1
|
L
 -22.7%
H
3.8
12.5
|
L
 -40.9%
H
3.8
16.5
|
L
 -79.6%
H
3.8
43.1
|
L
 -57.8%
H
3.8
49.1
|
| Natural Alternatives Intl Inc |
|
13.6
|
2.2
|
L
H
2.1
2.2
|
L
 6.4%
H
2.0
2.4
|
L
 -9.6%
H
2
2.6
|
L
 -14.9%
H
2
2.8
|
L
 -40.9%
H
2
5.0
|
L
 -65.4%
H
2
7.4
|
L
 -86.4%
H
2
17.8
|
L
 -79.0%
H
2
19.9
|
| Nature`s Sunshine Products Inc |
|
251.4
|
14.3
|
L
 0.7%
H
14.2
14.5
|
L
 -2.5%
H
14.0
15.0
|
L
 -30.0%
H
14.0
21.3
|
L
 -34.6%
H
14.0
22.5
|
L
 -13.4%
H
13.0
28.1
|
L
 -12.2%
H
10.8
28.1
|
L
 -17.3%
H
7.9
28.1
|
L
 1.6%
H
5.5
28.1
|
| Paranovus Entertainment Tech Ltd (Class A) |
|
4.6
|
5.3
|
L
 1.5%
H
5.2
5.5
|
L
 -9.2%
H
5
6.0
|
L
 9.9%
H
4.4
9.7
|
L
 -94.9%
H
3.8
2669
|
L
 -100.0%
H
3.8
148800
|
L
 -100.0%
H
3.8
530400
|
L
 -100.0%
H
3.8
2976000
|
L
H
3.8
14640000
|
| PharmaCyte Biotech Inc |
|
5.8
|
0.5
|
L
H
0.5
0.6
|
L
 3.9%
H
0.5
0.6
|
L
 -10%
H
0.5
0.6
|
L
 -33.3%
H
0.5
0.9
|
L
 -46.5%
H
0.5
1.5
|
L
 -77.5%
H
0.5
2.6
|
L
 -84.7%
H
0.5
4.1
|
L
 -99.1%
H
0.5
253.4
|
| Revolution Medicines Inc |
|
46,176.6
|
215.4
|
L
 1.9%
H
198.9
218.3
|
L
 -0.3%
H
198.9
220.3
|
L
 13.9%
H
178.1
220.3
|
L
 42.2%
H
141.4
220.3
|
L
 477.9%
H
35.6
220.3
|
L
 550.1%
H
15.5
220.3
|
L
 702.1%
H
14.1
220.3
|
L
H
14.1
220.3
|
| Scilex Holding Co |
|
39.5
|
5.6
|
L
 -0.7%
H
5.6
6.2
|
L
 -11.5%
H
5.5
6.5
|
L
 -18.0%
H
5.5
7.3
|
L
 -8.2%
H
5.4
10.4
|
L
 -68.9%
H
4.2
34.3
|
L
 70.5%
H
0.2
34.3
|
L
 -43.7%
H
0.2
34.3
|
L
H
0.2
34.3
|
| Upexi Inc |
|
77.9
|
1.1
|
L
 -2.8%
H
1
1.1
|
L
 34.2%
H
0.8
1.1
|
L
 32.5%
H
0.7
1.1
|
L
 -20.9%
H
0.7
1.4
|
L
 -87.6%
H
0.5
9.1
|
L
 -96.8%
H
0.5
39.8
|
L
 -99.0%
H
0.5
187.2
|
L
H
0.5
187.4
|
| Mira Pharma Inc |
|
31.5
|
0.8
|
L
 -3.9%
H
0.8
0.8
|
L
 -1.3%
H
0.7
0.8
|
L
 -14.8%
H
0.6
1.0
|
L
 -24.2%
H
0.6
1.2
|
L
 -46.0%
H
0.6
2.5
|
L
 -88.2%
H
0.5
6.8
|
L
H
0.5
8.0
|
L
H
0.5
8.0
|
| Scinai Immunotherapeutics Ltd (ADR) |
|
1.5
|
2.9
|
L
 -0.4%
H
2.8
3.1
|
L
 21.6%
H
2.3
3.6
|
L
 24.8%
H
2.2
3.8
|
L
 -37.7%
H
2.2
5
|
L
 -81.4%
H
2.2
16.8
|
L
 -97.8%
H
2.2
469
|
L
 -99.9%
H
2.2
3490
|
L
 -99.9%
H
2.2
62000
|
| Safety Shot Inc |
|
10.2
|
1.3
|
L
 5.8%
H
1.2
1.4
|
L
 37.6%
H
1.0
1.4
|
L
 14.3%
H
0.9
1.4
|
L
 -31.6%
H
0.9
2.1
|
L
 184.4%
H
0.1
7.2
|
L
H
0.1
7.5
|
L
H
0.1
7.5
|
L
H
0.1
7.5
|
| FitLife Brands Inc |
|
95.0
|
10.1
|
L
 0.7%
H
9.8
10.1
|
L
 -0.4%
H
9.8
10.6
|
L
 -1.3%
H
9.5
11.6
|
L
 0.5%
H
9.5
12.8
|
L
 -45.1%
H
8.7
21.0
|
L
 -38.9%
H
8.7
35.5
|
L
 -38.9%
H
8.7
35.5
|
L
 -38.9%
H
8.7
35.5
|
| Agape ATP Corp |
|
2.4
|
2.4
|
L
 1.3%
H
2.3
2.4
|
L
 -2.0%
H
2.3
2.5
|
L
 -2.4%
H
2.2
2.8
|
L
 -13.7%
H
2.2
8.5
|
L
 -96.4%
H
1.7
73.5
|
L
 -99.8%
H
1.7
1590
|
L
 -99.8%
H
1.7
1590
|
L
 -99.8%
H
1.7
1590
|
| Abivax (ADR) |
|
10,166.8
|
116.5
|
L
 -1.2%
H
116.0
118
|
L
 -2.0%
H
113.3
121.5
|
L
 -7.3%
H
113.3
133.5
|
L
 -4.5%
H
69.8
148.0
|
L
 46.2%
H
69.8
148.8
|
L
H
4.8
148.8
|
L
H
4.8
148.8
|
L
H
4.8
148.8
|
| ArriVent BioPharma Inc |
|
1,535.4
|
31.1
|
L
 -0.7%
H
30.1
31.4
|
L
 3.8%
H
28.1
31.5
|
L
 -1.9%
H
28.1
32.7
|
L
 16.5%
H
26.6
35.8
|
L
 59.0%
H
17
35.8
|
L
H
14.4
36.2
|
L
H
14.4
36.2
|
L
H
14.4
36.2
|
| Synergy CHC Corp |
|
1.5
|
0.1
|
L
H
0.1
0.1
|
L
 -9.1%
H
0.1
0.1
|
L
 -41.2%
H
0.1
0.2
|
L
 -61.5%
H
0.1
0.4
|
L
 -95.7%
H
0.1
3.0
|
L
H
0.1
4.6
|
L
H
0.1
4.6
|
L
H
0.1
4.6
|
| iBio Inc |
|
71.0
|
1.4
|
L
 -2.7%
H
1.4
1.5
|
L
 -1.4%
H
1.4
1.5
|
L
H
1.3
1.5
|
L
 -22.3%
H
1.3
2.1
|
L
 81.0%
H
0.8
3.8
|
L
 78.8%
H
0.6
3.8
|
L
 78.8%
H
0.6
3.8
|
L
 78.8%
H
0.6
3.8
|
| Curanex Pharma Inc |
|
7.2
|
4.6
|
L
 -3.2%
H
4.4
4.7
|
L
 1990.9%
H
0.2
6
|
L
 2321.1%
H
0.2
6
|
L
 1293.9%
H
0.2
6
|
L
 14.4%
H
0.2
9.2
|
L
 14.4%
H
0.2
9.2
|
L
 14.4%
H
0.2
9.2
|
L
 14.4%
H
0.2
9.2
|